**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 32740-79-7 |Ruthenium(IV) oxide hydrate | ca. 100 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI O
Risk Phrases: 36/38 8
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes and skin. Contact with combustible material may
cause fire.The toxicological properties of this material have not
been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation. May cause conjunctivitis. May cause
permanent corneal opacification.
Skin:
Causes skin irritation.
Ingestion:
The toxicological properties of this substance have not been fully
investigated. May cause burns to the gastrointestinal tract. May
cause nausea, vomiting, and diarrhea, possibly with blood.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. May cause acute
pulmonary edema, asphyxia, chemical pneumonitis, and upper airway
obstruction caused by edema.
Chronic:
Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse. Remove contaminated clothing and shoes.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Strong oxidizer. Contact with other material may
cause fire. During a fire, irritating and highly toxic gases may be
generated by thermal decomposition or combustion. Use water with
caution and in flooding amounts.
Extinguishing Media:
Contact professional fire-fighters immediately. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Remove all sources of
ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Do not get in eyes, on
skin, or on clothing. Keep container tightly closed. Do not ingest or
inhale. Wash clothing before reuse. Keep from contact with clothing
and other combustible materials.
Storage:
Keep away from heat, sparks, and flame. Do not store near
combustible materials. Store in a tightly closed container. Store in
a cool, dry, well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 32740-79-7:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: black
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: insoluble
Specific Gravity/Density: Not available.
Molecular Formula: O2Ru.xH2O
Molecular Weight: 133.07
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, ignition sources, dust generation, excess
heat, combustible materials, reducing agents, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 32740-79-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Ruthenium(IV) oxide hydrate -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI O
Risk Phrases:
R 36/38 Irritating to eyes and skin.
R 8 Contact with combustible material may cause
fire.
Safety Phrases:
S 7/8 Keep container tightly closed and dry.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 32740-79-7: 0
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 32740-79-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 32740-79-7 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #6 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Piperonal, 99%
| 120-57-0 |
|
5-Chlorouracil, 99%
| 1820-81-1 |
|
Benzáa??anthracene-7,12-dione, 97% (uv-vis)
| 2498-66-0 |
|
(3,4-Dimethoxyphenyl)acetic acid, 99%
| 93-40-3 |
|
1-Naphthaleneacetamide, 98%
| 86-86-2 |
|
Chlorosulfonyl isocyanate, 98+%
| 1189-71-5 |
|
4-Chloro-4'-Fluorobutyrophenone, 97+% (GC)
| 3874-54-2 |
|
Vitamin d2 (calciferol),99% (hplc)
| 50-14-6 |
|
Diethyl Phosphonoacetaldehyde Diethyl Acetal, Tech. 90%
| 7598-61-0 |
|
3,5-Dimethoxyacetophenone, 97%
| 39151-19-4 |
|
Palladium on Activated Carbon (5% Pd)
| |
|
Cyclododecene, Tech., Predominantly Trans
| 1501-82-2 |
|
4-Hydroxy-6-methyl-2-pyrone
| 675-10-5 |
|
Benzoyl bromide, 97%
| 618-32-6 |
|
Prostaglandin e1, 98+%
| 745-65-3 |
|
4,4'-Dimethylbenzil, 99+%
| 3457-48-5 |
|
Chrysoidin
| 532-82-1 |
|
d-Limonene
| 5989-27-5 |
|
Mitomycin C (Contains 2mg Mitomycin C and 48mg Sodium Chloride)
| 50-07-7 |
|
Butyl methacrylate/isobutyl methacrylate copolymer, high molecular
| 9011-53-4 |
|
Bis-(2-Methylallyl)Cycloocta-1,5-Diene Ruthenium(II) Complex
| 0-00-1 |
|
d-Lysergic acid hydrate, 95% *** controled product kb 11.6.87 ***
| 82-58-6 |
|
2-Bromo-1-Indanol, 99%
| 5400-80-6 |
|
Ruthenium(IV) oxide hydrate
| 32740-79-7 |
|
2-Chlorocyclohexanol, Tech., 90%
| 1561-86-0 |
|
5-Amino-2,2,4-Trimethyl-1-Cyclopentane-Methylamine, 99%, Mixture of
| 67907-32-8 |
|
2,3,4-Trimethoxybenzoic acid, 98+%
| 573-11-5 |
|
1,3-Dibromo-5,5-dimethylhydantoin, 98%
| 77-48-5 |
|
Dicumarol, 99%
| 66-76-2 |
|
Tetraphenylphosphonium Chloride 99%
| 2001-45-8 |
|
Benzo[k]fluoranthene, 99+% (tlc)
| 207-08-9 |
|
Dihexylamine, 99+% (GC)
| 143-16-8 |
|
Propargyl Alcohol, 99%
| 107-19-7 |
|
Borane-tert-butylamine complex, powder
| 7337-45-3 |
|
Tri-n-butyltin methoxide, 97%
| 1067-52-3 |
|
5-Methoxyindole-3-Carboxaldehyde, 99+%
| 10601-19-1 |
|
2,4-Dichlorophenoxyacetic acid
| 94-75-7 |
|
4-Phenylpyridine, 99%
| 939-23-1 |
|
2-Naphthalenesulfonic acid hydrate, 99%
| 120-18-3 |
|
Benzanthrone, 99%
| 82-05-3 |
|
Tripentylamine, 99%
| 621-77-2 |
|
BOC-D-Arginine Hydrochloride, Hydrate, 99%
| 114622-81-0 |
|
Phenylphosphonothioic dichloride, 97%
| 3497-00-5 |
|
3,3,5,5-Tetramethylpyrroline-N-Oxide, 98%
| 10135-38-3 |
|
1-(2-Aminoethyl)-2-Methyl-5-Nitroimidazole Dihydrochloride
| 49575-10-2 |
|
Bis(2-ethylhexyl) adipate
| 103-23-1 |
|
M-Tolyl Acetate
| 122-46-3 |
|
1,4-Dioxa-8-azaspiro(4.5)decane, 98%
| 177-11-7 |
|
DL-Homocysteinethiolactone Hydrochloride, 99%
| 6038-19-3 |
|
Ethyl Benzoate, 99+%
| 93-89-0 |
|
|